Cytosorbents Corp — Form 8-K
Filed July 6, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 88/100
What the filing says
Cytosorbents Corp filed an 8-K on July 6, 2026 reporting Item 3.01 — Notice of Delisting or Failure to Satisfy Continued Listing Rule or Standard; Transfer of Listing. The filing does not disclose specific reasons, counterparties, dollar amounts, dates of non-compliance, or remediation timeline in the metadata provided. The core fact is a delisting notice; substantive details are absent from this extract.
Why this rating
Delisting is business-changing for any public company regardless of size — eliminates capital market access, liquidity, and investor base. Relative to $60.6M market cap, this threatens survival.
Extracted items
See more from July 6, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.